Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy

Fig. 1

Usefulness of serological inflammation markers in detecting active RA (requiring a change of their disease modifying anti-rheumatic drug, grey box plots) from not active RA (white box plots). Shown are calprotectin (a, d), ESR (b, e), and CRP values (c, f) in tocilizumab (TCZ)-treated RA patients (ac) and in tumor necrosis factor alpha-inhibitor (TNFi)-treated RA (df) patients. Boxplots show medians with 25th and 75th percentiles; whiskers indicate minimums and maximums, respectively. *Significant differences in a Mann-Whitney U test

Back to article page